Your browser doesn't support javascript.
loading
Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.
Ju, Mingyi; Zhang, Jiaojiao; Deng, Zhuoyuan; Wei, Minjie; Ma, Lianghua; Chen, Ting; Zhao, Lin.
Afiliação
  • Ju M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Zhang J; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
  • Deng Z; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Wei M; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
  • Ma L; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Chen T; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
  • Zhao L; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
J Immunother Cancer ; 12(7)2024 Jul 31.
Article em En | MEDLINE | ID: mdl-39089739
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-23 / Antígeno CTLA-4 Limite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-23 / Antígeno CTLA-4 Limite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido